What is the Impact Factor of Metabolic Brain Disease?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Metabolic Brain Disease is 3.80, ranking in quartile Q2 of Web of Science (SCIE).

Is Metabolic Brain Disease indexed in Web of Science or Scopus?

Yes, Metabolic Brain Disease is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.995 (Q2) and an H-index of 87.

Who publishes Metabolic Brain Disease and what is the Article Processing Charge (APC)?

Metabolic Brain Disease is published by Springer US. The estimated Article Processing Charge (APC) is approximately $3,232 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Metabolic Brain Disease?

The official ISO-4 abbreviation of Metabolic Brain Disease is "METAB BRAIN DIS" with common acronym "mebr". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #4,949Hybrid

Metabolic Brain Disease

Acronym:mebr

•

Abbreviation (ISO):METAB BRAIN DIS

•

Identifier (ISSN):0885-7490(Print)/1573-7365(Online)

•

Publisher:Springer US

Official Website Submission Portal Compare

Clarivate IF (2026)

3.8↑ +0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Metabolic Brain Disease

WoS Q2

Annual Impact Factor Metric

Current (2026):3.8

Scopus SJR & RankScopus Q2

0.995

#4,949

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

87 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate3.1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

219articles/year

17.44% Gold OA•84.79% Original Research

Aims & Scope

Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to physicians, neuroscientists, internists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders.

Topics Covered (Recognized by AI)

Biology99.2%Medicine98.8%Internal medicine92.1%Psychology81.8%Chemistry79.1%Biochemistry76.4%Neuroscience74.2%Endocrinology72.7%Genetics63.8%Psychiatry63.6%Pathology43.4%Organic chemistry36.8%Physics32.3%Pharmacology29.4%Neurology28.6%Nuclear magnetic resonance25.1%Receptor24%Enzyme23.6%Immunology22.1%Disease21.8%Gene20.8%

Primary Research Areas

Medicine Endocrinology & Metabolism

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Rank77/198

IndexSCIE

JCRSCIE2026

NEUROSCIENCES

Rank118/330

IndexSCIE

JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Rank82/198

IndexSCIE

JCISCIE2026

NEUROSCIENCES

Rank157/330

IndexSCIE

Category	Index	Rank	Quartile
ENDOCRINOLOGY & METABOLISM	JCRSCIE	77/198	Q2
NEUROSCIENCES	JCRSCIE	118/330	Q2
ENDOCRINOLOGY & METABOLISM	JCISCIE	82/198	Q2
NEUROSCIENCES	JCISCIE	157/330	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.8

Articles / Year203

Total Citations87

2025

IF3.5

Articles / Year267

Total Citations1,227

2024

IF3.2

Articles / Year162

Total Citations1,181

2023

IF3.6

Articles / Year184

Total Citations1,976

2022

IF3.655

Articles / Year272

Total Citations4,007

Year	Impact Factor	Articles / Year	Total Citations
2026	3.8	203	87
2025	3.5	267	1,227
2024	3.2	162	1,181
2023	3.6	184	1,976
2022	3.655	272	4,007
2021	3.584	225	4,833
2020	2.726	121	3,044
2019	2.411	162	4,254
2018	2.441	188	5,427
2017	—	228	6,350
2016	—	162	4,904
2015	—	134	3,742

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,949Scopus Q2SCImago Profile

Scopus Coverage:1986-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicineNeuroscience

Scopus Citation Rank (SJR)Q2

0.995

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

4.18

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,232 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,466

3-Year Documents555

Citable Documents548

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ2

Cellular and Molecular NeuroscienceQ2

Neurology (clinical)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 3.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ENDOCRINOLOGY & METABOLISM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Metabolic Brain Disease (acronym: mebr, abbr: METAB BRAIN DIS, ISSN: 0885-7490) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer US in United States since 1986. The periodical holds a Journal Impact Factor (JIF) of 3.80, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.995 (Q2), an H-index of 87.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 219 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,232 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.